Psoriasis Drugs Market: Global Industry Share, Future Growth, Trends, Size and F
Posted by Steve Sharma on March 25th, 2022
Psoriasis is a chronic inflammatory skin disease that occurs due to genetic disposition and environmental factors. Psoriasis is a systemic disease associated with psychological, metabolic, arthritic, and cardiovascular comorbidities. On an average, psoriasis affects around 2 – 3% of the population globally.
Plaque psoriasis, being the number one and most common indication, held nearly 85% share of the US$ 11.37 Bn psoriasis drugs market in 2021, with the market estimated to expand at a CAGR of nearly 6.5% over the next ten years.
An array of agents exist for the symptomatic treatment of psoriasis. Patients with mild-to-moderate psoriasis typically receive topical treatments that modulate gene transcription, promote keratinocyte differentiation, and inhibit cell proliferation.
Planning Forward? Access Sample Of Psoriasis Drugs Market Report! https://www.persistencemarketresearch.com/samples/25102
Like it? Share it!
About the AuthorSteve Sharma
Joined: April 12th, 2021
Articles Posted: 443
More by this author